Clinical Trials Browser

Peritoneal Neoplasms × Doxorubicin × Clear all

NCT04847063 2026-03-06

Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies

Phase 1 Recruiting

GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms

NCT03287375 2022-10-07

PIPAC-OPC2

Phase 2 Completed

Peritoneal Neoplasms

NCT00262990 2020-12-17

Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

Phase 3 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence

NCT02604784 2020-09-17

PI-CaP

Phase 1/2 Completed

Peritoneal Neoplasms

NCT02320448 2017-09-12

Treating Peritoneal Carcinomatosis With PIPAC

Phase 2 Completed

Peritoneal Neoplasms

NCT03034850 2017-01-27

Thrombin Generation and Platelet Activation in CRS/HIPEC

GynecologicOther solid neoplasmThoracic

Mesothelioma, Peritoneal Neoplasms, Pseudomyxoma Peritonei